OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase
Abigail G. Kelly, Weicang Wang, Eva Rothenberger, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 7
Open Access | Times Cited: 12

Showing 12 citing articles:

Immunoregulatory mechanisms of the arachidonic acid pathway in cancer
Maria Tredicine, Matteo Mucci, Antonio Recchiuti, et al.
FEBS Letters (2025)
Open Access

Aspirin-triggered DHA metabolites inhibit angiogenesis
Marianela Vara-Messler, Lucia Trevisi, Elisabetta Zulato, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

A Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan‐Cancer
Weiquan Hu, Xiaoli Ding, Xiangsheng Wu, et al.
Cancer Reports (2025) Vol. 8, Iss. 3
Open Access

Optimization of D-amino acid oxidase and epoxide hydrolase through high-performance characterization for targeted cancer therapy in sustainable biocatalysis
Huijun Yu, Siyi Li, Jingyang Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 142784-142784
Closed Access

Identification of high-affinity inhibitors for epoxide hydrolase 2 from repurposed drugs in Parkinson’s disease therapeutics
Anas Shamsi, Moyad Shahwan, Sohaib Naseem Khan, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-12
Closed Access

Harnessing Oxylipins and Inflammation Modulation for Prevention and Treatment of Colorectal Cancer
Julius Gretschel, Racha El Hage, Ruirui Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5408-5408
Open Access | Times Cited: 2

Exploring the Unique Role of Specialized Pro-Resolving Mediators in Cancer Therapeutics
Katherine Quinlivan, Isabella Howard, Franciska Southan, et al.
Prostaglandins & Other Lipid Mediators (2024), pp. 106944-106944
Closed Access | Times Cited: 1

Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit–risk ratio of immuno-oncology therapy
David A. Potter, Zhijun Guo, Jianxun Lei, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 9
Open Access

Upregulated Nuclear Expression of Soluble Epoxide Hydrolase Predicts Poor Outcome in Breast Cancer Patients: Importance of the Digital Pathology Approach
Mayra Montecillo-Aguado, Giovanny Soca‐Chafre, Gabriela Antonio-Andrés, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8024-8024
Open Access

Targeting the soluble epoxide hydrolase pathway as a novel therapeutic approach for the treatment of pain
James Turnbull, Victoria Chapman
Current Opinion in Pharmacology (2024) Vol. 78, pp. 102477-102477
Open Access

Intradomain Allosteric Regulation of Soluble Epoxide Hydrolase by Its Substrates
Shoji Matsumura, A Shida, Moeno Tsuchii, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13496-13496
Open Access

Page 1

Scroll to top